National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Denosumab May Help Prevent Bone Loss

Bortezomib for Initial Therapy in Multiple Myeloma

Past Highlights
 
 
Results: 1 -2 of 2    Show     results per page
View Search Criteria | Help With Results
Title 
Phase sort descending
Protocol IDs 
 
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

   
Phase III, Phase II

   
WCTU-SCOPE-1
EU-20739, EUDRACT-2006-002241-37, ISRCTN47718479, CTA-17853/0202/001-0001, NCT00509561

 
 
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer

   
Phase III

   
RTOG-0436
RTOG-0436, NCT00655876

 
     

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov